Injunctive Relief Information


AmerisourceBergen has agreed to a nationwide settlement that resolves most of the opioid-related lawsuits filed by state and local government entities across the country. As part of the agreement, court-ordered injunctive relief will apply to each distributor’s Controlled Substance Monitoring Program. We expect that the injunctive relief terms will go into effect in July 2022 and this page will contain all of the information and resources to ensure that all of our independent retail, chain retail and mail order pharmacy customers are prepared for the new requirements.

Injunctive relief letter from AmerisourceBergen

Injunctive relief letter from AmerisourceBergen, McKesson and Cardinal Health

Report an issue related to the diversion of controlled substances.

Use our Reporting Hotline to confidentially report any concerns.